---
title: "Top 10 HK Stock Losers (5.13)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286223324.md"
description: "QINGSONG HEALTH(02661) fell 24.2%, with a trading turnover 244.8 Million HKD, and a year-to-date fell 57.2%. CHINA STAR ENT(00326) fell 20.14%, with a trading turnover 119.0 Million HKD, and a year-to-date rose 123.4%. PEGBIO CO-B(02565) fell 19.15%, with a trading turnover 53.6 Million HKD, and a year-to-date fell 71.7%."
datetime: "2026-05-13T08:30:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286223324.md)
  - [en](https://longbridge.com/en/news/286223324.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286223324.md)
---

# Top 10 HK Stock Losers (5.13)

Hang Seng Index has rose 0.15%, with a year-to-date rose 3%; Hang Seng TECH Index has rose 0.46%, with a year-to-date fell 7.7%.

QINGSONG HEALTH(02661) fell 24.2%, with a trading turnover 244.8 Million HKD, and a year-to-date fell 57.2%.

CHINA STAR ENT(00326) fell 20.14%, with a trading turnover 119.0 Million HKD, and a year-to-date rose 123.4%.

PEGBIO CO-B(02565) fell 19.15%, with a trading turnover 53.6 Million HKD, and a year-to-date fell 71.7%.

### Related Stocks

- [02661.HK](https://longbridge.com/en/quote/02661.HK.md)
- [00326.HK](https://longbridge.com/en/quote/00326.HK.md)
- [02565.HK](https://longbridge.com/en/quote/02565.HK.md)
- [01626.HK](https://longbridge.com/en/quote/01626.HK.md)
- [02255.HK](https://longbridge.com/en/quote/02255.HK.md)
- [09936.HK](https://longbridge.com/en/quote/09936.HK.md)
- [02575.HK](https://longbridge.com/en/quote/02575.HK.md)
- [00290.HK](https://longbridge.com/en/quote/00290.HK.md)
- [09887.HK](https://longbridge.com/en/quote/09887.HK.md)
- [02632.HK](https://longbridge.com/en/quote/02632.HK.md)

## Related News & Research

- [QingSong Health Names Veteran Dealmaker as New CFO to Drive AI Health Growth](https://longbridge.com/en/news/286788421.md)
- [QingSong Health Sets 2026 AGM to Renew Board and Seek 10% Share Buyback Mandate](https://longbridge.com/en/news/284810464.md)
- [Xuanzhu Biopharmaceutical Wins CSRC Nod for H Share Full Circulation Plan](https://longbridge.com/en/news/282442087.md)
- [Nanjing Leads Biolabs Calls 2026 AGM and Seeks Fresh Share Issuance Mandate](https://longbridge.com/en/news/284020496.md)
- [QingSong Health Sets March Board Meeting to Approve 2025 Results and Mull Dividend](https://longbridge.com/en/news/278543076.md)